Laird Superfood plunges on earnings miss, margin compression
Gross margins decline amid commodity headwinds despite Navitas acquisition completion
Laird Superfood shares tumbled after the functional food company reported fourth-quarter earnings that missed analyst expectations by a wide margin, with losses widening significantly and gross margins deteriorating despite a recent $38.5 million acquisition to bolster growth.
The company reported an adjusted loss per share of 16 cents for the quarter, far worse than the consensus estimate of a 4-cent loss, representing a 269.5% shortfall relative to Wall Street expectations. Revenue declined 5.6% to $13.3 million, falling short of the $14.1 million analysts had anticipated.
Gross margins compressed sharply to 34.1% from 38.6% in the prior-year period, driven by commodity and tariff headwinds that have pressured profitability across the packaged food sector. The net loss widened to $1.8 million from $400,000 a year earlier, according to the company's earnings release.
Despite the quarterly weakness, wholesale channel performance provided a bright spot, surging 44% year-over-year and partially offsetting weakness in the direct-to-consumer e-commerce segment. The mixed results reflect broader challenges facing functional food brands as consumers increasingly trade down to lower-priced alternatives in a high-inflation environment.
The earnings report comes just two weeks after Laird Superfood completed its acquisition of Navitas LLC, the parent company of Navitas Organics, for $38.5 million in cash. The transaction was funded through a concurrent $50 million private placement of Series A Convertible Preferred Stock to affiliates of Nexus Capital Management LP, which now holds approximately 53.5% of the company's outstanding shares on a diluted basis.
Chief Executive Officer Jason Vieth described the acquisition as "a significant step in building a scaled and diversified platform in functional nutrition" when the deal was announced in December. The combination aims to create a leading positive nutrition platform with enhanced product breadth and supply chain capabilities.
For fiscal year 2026, the company provided guidance for high single-digit revenue growth on a combined basis, targeting a $95.2 million revenue base. Management indicated that adjusted EBITDA should improve throughout the year, though formal financial guidance will be provided with the first-quarter 2026 earnings release.
The company achieved record net sales of $49.9 million for fiscal year 2025, marking 15% year-over-year growth. However, the stock has struggled to maintain momentum, with shares down approximately 51% over the past year despite the strategic expansion.
Analysts had maintained a bullish outlook heading into earnings, with a Strong Buy consensus rating and an average price target of $7.67—more than triple the current share price of $2.23. Craig-Hallum recently lowered its price target to $11 from $12 while maintaining a Buy rating, citing previous quarterly results that showed topline shortfalls.
The stark earnings miss raises questions about Laird Superfood's path to profitability as it integrates Navitas and navigates a challenging consumer environment. The company's market capitalization of approximately $23.7 million remains well below analyst valuation targets, suggesting significant execution risk remains even as management projects margin improvement in the year ahead.